2018–19 year to date performance overview

Between 01 July 2018 and 30 June 2019, the APVMA:

  • finalised 135 applications for pre-application assistance
  • received 2531 new product, active and permit applications for preliminary assessment
  • commenced assessment/evaluation of 2883 product, active and permit applications
  • finalised 2992 product, active and permit applications
  • overall timeframe performance was 85 per cent for product, active and permit applications types with:
    • 85 per cent of applications for pesticides completed in timeframe
    • 81 per cent of applications for veterinary medicines completed in timeframe
    • 92 per cent of applications for actives completed in timeframe
    • 84 per cent of applications for permits completed in timeframe
  • 85 per cent of the 1202 applications in progress are within timeframe
  • 57 per cent of applications requiring major assessment for pesticides were completed within timeframe
  • 58 per cent of applications requiring major assessment for veterinary medicines were completed within timeframe
  • 99 per cent of non-technical applications for pesticides were completed within timeframe
  • 90 per cent of non-technical applications for veterinary medicines were completed within timeframe.

Summary of activities related to regulatory decisions July 2018–June 2019

Summary of activities related to regulatory decisions July 2018–June 2019 

Types of regulatory decisions*

Commenced

Finalised/issued

In progress

Pre-application assistance

142

135

23

Product registration—pesticides

1144

1189

451

Product registration—veterinary medicines

828

820

300

Actives

300

456

202

Permits

611

527

249

Items 8L, 8M, 8P

576

575

47

Item 25

16

13

8

Notifiable variations

694

691

3

Import consents

535

522

6

Certificates of export

303

286

38

Total

5149

5214

1327

*See description of application types.

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.